Come up with a name for your new list and we'll add to it:
Cequent Pharmaceuticals raised a round of funding on , . Investors include
Beth Israel Deaconess Medical Center.
Cequent is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of …